Global Microneedle Flu Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Microneedle Flu Vaccine market size was valued at US$ 1391.1 million in 2023. With growing demand in downstream market, the Microneedle Flu Vaccine is forecast to a readjusted size of US$ 2051.3 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Microneedle Flu Vaccine market. Microneedle Flu Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Microneedle Flu Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Microneedle Flu Vaccine market.
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Microneedle Flu Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Microneedle Flu Vaccine market. It may include historical data, market segmentation by Type (e.g., Solid Microneedle, Hollow Microneedle), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Microneedle Flu Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Microneedle Flu Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Microneedle Flu Vaccine industry. This include advancements in Microneedle Flu Vaccine technology, Microneedle Flu Vaccine new entrants, Microneedle Flu Vaccine new investment, and other innovations that are shaping the future of Microneedle Flu Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Microneedle Flu Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Microneedle Flu Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Microneedle Flu Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Microneedle Flu Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Microneedle Flu Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Microneedle Flu Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Microneedle Flu Vaccine market.
Market Segmentation:
Microneedle Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Microneedle Flu Vaccine market?
What factors are driving Microneedle Flu Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microneedle Flu Vaccine market opportunities vary by end market size?
How does Microneedle Flu Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Microneedle Flu Vaccine market size was valued at US$ 1391.1 million in 2023. With growing demand in downstream market, the Microneedle Flu Vaccine is forecast to a readjusted size of US$ 2051.3 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Microneedle Flu Vaccine market. Microneedle Flu Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Microneedle Flu Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Microneedle Flu Vaccine market.
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Microneedle Flu Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Microneedle Flu Vaccine market. It may include historical data, market segmentation by Type (e.g., Solid Microneedle, Hollow Microneedle), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Microneedle Flu Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Microneedle Flu Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Microneedle Flu Vaccine industry. This include advancements in Microneedle Flu Vaccine technology, Microneedle Flu Vaccine new entrants, Microneedle Flu Vaccine new investment, and other innovations that are shaping the future of Microneedle Flu Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Microneedle Flu Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Microneedle Flu Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Microneedle Flu Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Microneedle Flu Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Microneedle Flu Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Microneedle Flu Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Microneedle Flu Vaccine market.
Market Segmentation:
Microneedle Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Solid Microneedle
- Hollow Microneedle
- Coated Microneedle
- Dissolving Microneedle
- Influenza A
- Influenza B
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- GC Pharma
- Debiotech
- NanoPass Technologies
- Corium International
- Becton Dickinson and Company
- FluGen
- CosMED Pharmaceuticals
- Microdermics and OraSure Technologies
What is the 10-year outlook for the global Microneedle Flu Vaccine market?
What factors are driving Microneedle Flu Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microneedle Flu Vaccine market opportunities vary by end market size?
How does Microneedle Flu Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microneedle Flu Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Microneedle Flu Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Microneedle Flu Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Microneedle Flu Vaccine Segment by Type
2.2.1 Solid Microneedle
2.2.2 Hollow Microneedle
2.2.3 Coated Microneedle
2.2.4 Dissolving Microneedle
2.3 Microneedle Flu Vaccine Sales by Type
2.3.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Microneedle Flu Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Microneedle Flu Vaccine Sale Price by Type (2019-2024)
2.4 Microneedle Flu Vaccine Segment by Application
2.4.1 Influenza A
2.4.2 Influenza B
2.5 Microneedle Flu Vaccine Sales by Application
2.5.1 Global Microneedle Flu Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Microneedle Flu Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Microneedle Flu Vaccine Sale Price by Application (2019-2024)
3 GLOBAL MICRONEEDLE FLU VACCINE BY COMPANY
3.1 Global Microneedle Flu Vaccine Breakdown Data by Company
3.1.1 Global Microneedle Flu Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Microneedle Flu Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Microneedle Flu Vaccine Revenue by Company (2019-2024)
3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Microneedle Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Microneedle Flu Vaccine Product Location Distribution
3.4.2 Players Microneedle Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MICRONEEDLE FLU VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Microneedle Flu Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Microneedle Flu Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Microneedle Flu Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Microneedle Flu Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Microneedle Flu Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Microneedle Flu Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Microneedle Flu Vaccine Sales Growth
4.4 APAC Microneedle Flu Vaccine Sales Growth
4.5 Europe Microneedle Flu Vaccine Sales Growth
4.6 Middle East & Africa Microneedle Flu Vaccine Sales Growth
5 AMERICAS
5.1 Americas Microneedle Flu Vaccine Sales by Country
5.1.1 Americas Microneedle Flu Vaccine Sales by Country (2019-2024)
5.1.2 Americas Microneedle Flu Vaccine Revenue by Country (2019-2024)
5.2 Americas Microneedle Flu Vaccine Sales by Type
5.3 Americas Microneedle Flu Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microneedle Flu Vaccine Sales by Region
6.1.1 APAC Microneedle Flu Vaccine Sales by Region (2019-2024)
6.1.2 APAC Microneedle Flu Vaccine Revenue by Region (2019-2024)
6.2 APAC Microneedle Flu Vaccine Sales by Type
6.3 APAC Microneedle Flu Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Microneedle Flu Vaccine by Country
7.1.1 Europe Microneedle Flu Vaccine Sales by Country (2019-2024)
7.1.2 Europe Microneedle Flu Vaccine Revenue by Country (2019-2024)
7.2 Europe Microneedle Flu Vaccine Sales by Type
7.3 Europe Microneedle Flu Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microneedle Flu Vaccine by Country
8.1.1 Middle East & Africa Microneedle Flu Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Microneedle Flu Vaccine Sales by Type
8.3 Middle East & Africa Microneedle Flu Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine
10.3 Manufacturing Process Analysis of Microneedle Flu Vaccine
10.4 Industry Chain Structure of Microneedle Flu Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Microneedle Flu Vaccine Distributors
11.3 Microneedle Flu Vaccine Customer
12 WORLD FORECAST REVIEW FOR MICRONEEDLE FLU VACCINE BY GEOGRAPHIC REGION
12.1 Global Microneedle Flu Vaccine Market Size Forecast by Region
12.1.1 Global Microneedle Flu Vaccine Forecast by Region (2025-2030)
12.1.2 Global Microneedle Flu Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Microneedle Flu Vaccine Forecast by Type
12.7 Global Microneedle Flu Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Microneedle Flu Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GC Pharma
13.2.1 GC Pharma Company Information
13.2.2 GC Pharma Microneedle Flu Vaccine Product Portfolios and Specifications
13.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GC Pharma Main Business Overview
13.2.5 GC Pharma Latest Developments
13.3 Debiotech
13.3.1 Debiotech Company Information
13.3.2 Debiotech Microneedle Flu Vaccine Product Portfolios and Specifications
13.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Debiotech Main Business Overview
13.3.5 Debiotech Latest Developments
13.4 NanoPass Technologies
13.4.1 NanoPass Technologies Company Information
13.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
13.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 NanoPass Technologies Main Business Overview
13.4.5 NanoPass Technologies Latest Developments
13.5 Corium International
13.5.1 Corium International Company Information
13.5.2 Corium International Microneedle Flu Vaccine Product Portfolios and Specifications
13.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Corium International Main Business Overview
13.5.5 Corium International Latest Developments
13.6 Becton Dickinson and Company
13.6.1 Becton Dickinson and Company Company Information
13.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolios and Specifications
13.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Becton Dickinson and Company Main Business Overview
13.6.5 Becton Dickinson and Company Latest Developments
13.7 FluGen
13.7.1 FluGen Company Information
13.7.2 FluGen Microneedle Flu Vaccine Product Portfolios and Specifications
13.7.3 FluGen Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 FluGen Main Business Overview
13.7.5 FluGen Latest Developments
13.8 CosMED Pharmaceuticals
13.8.1 CosMED Pharmaceuticals Company Information
13.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolios and Specifications
13.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CosMED Pharmaceuticals Main Business Overview
13.8.5 CosMED Pharmaceuticals Latest Developments
13.9 Microdermics and OraSure Technologies
13.9.1 Microdermics and OraSure Technologies Company Information
13.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
13.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Microdermics and OraSure Technologies Main Business Overview
13.9.5 Microdermics and OraSure Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microneedle Flu Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Microneedle Flu Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Microneedle Flu Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Microneedle Flu Vaccine Segment by Type
2.2.1 Solid Microneedle
2.2.2 Hollow Microneedle
2.2.3 Coated Microneedle
2.2.4 Dissolving Microneedle
2.3 Microneedle Flu Vaccine Sales by Type
2.3.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Microneedle Flu Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Microneedle Flu Vaccine Sale Price by Type (2019-2024)
2.4 Microneedle Flu Vaccine Segment by Application
2.4.1 Influenza A
2.4.2 Influenza B
2.5 Microneedle Flu Vaccine Sales by Application
2.5.1 Global Microneedle Flu Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Microneedle Flu Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Microneedle Flu Vaccine Sale Price by Application (2019-2024)
3 GLOBAL MICRONEEDLE FLU VACCINE BY COMPANY
3.1 Global Microneedle Flu Vaccine Breakdown Data by Company
3.1.1 Global Microneedle Flu Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Microneedle Flu Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Microneedle Flu Vaccine Revenue by Company (2019-2024)
3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Microneedle Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Microneedle Flu Vaccine Product Location Distribution
3.4.2 Players Microneedle Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MICRONEEDLE FLU VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Microneedle Flu Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Microneedle Flu Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Microneedle Flu Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Microneedle Flu Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Microneedle Flu Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Microneedle Flu Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Microneedle Flu Vaccine Sales Growth
4.4 APAC Microneedle Flu Vaccine Sales Growth
4.5 Europe Microneedle Flu Vaccine Sales Growth
4.6 Middle East & Africa Microneedle Flu Vaccine Sales Growth
5 AMERICAS
5.1 Americas Microneedle Flu Vaccine Sales by Country
5.1.1 Americas Microneedle Flu Vaccine Sales by Country (2019-2024)
5.1.2 Americas Microneedle Flu Vaccine Revenue by Country (2019-2024)
5.2 Americas Microneedle Flu Vaccine Sales by Type
5.3 Americas Microneedle Flu Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microneedle Flu Vaccine Sales by Region
6.1.1 APAC Microneedle Flu Vaccine Sales by Region (2019-2024)
6.1.2 APAC Microneedle Flu Vaccine Revenue by Region (2019-2024)
6.2 APAC Microneedle Flu Vaccine Sales by Type
6.3 APAC Microneedle Flu Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Microneedle Flu Vaccine by Country
7.1.1 Europe Microneedle Flu Vaccine Sales by Country (2019-2024)
7.1.2 Europe Microneedle Flu Vaccine Revenue by Country (2019-2024)
7.2 Europe Microneedle Flu Vaccine Sales by Type
7.3 Europe Microneedle Flu Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microneedle Flu Vaccine by Country
8.1.1 Middle East & Africa Microneedle Flu Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Microneedle Flu Vaccine Sales by Type
8.3 Middle East & Africa Microneedle Flu Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine
10.3 Manufacturing Process Analysis of Microneedle Flu Vaccine
10.4 Industry Chain Structure of Microneedle Flu Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Microneedle Flu Vaccine Distributors
11.3 Microneedle Flu Vaccine Customer
12 WORLD FORECAST REVIEW FOR MICRONEEDLE FLU VACCINE BY GEOGRAPHIC REGION
12.1 Global Microneedle Flu Vaccine Market Size Forecast by Region
12.1.1 Global Microneedle Flu Vaccine Forecast by Region (2025-2030)
12.1.2 Global Microneedle Flu Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Microneedle Flu Vaccine Forecast by Type
12.7 Global Microneedle Flu Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Microneedle Flu Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GC Pharma
13.2.1 GC Pharma Company Information
13.2.2 GC Pharma Microneedle Flu Vaccine Product Portfolios and Specifications
13.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GC Pharma Main Business Overview
13.2.5 GC Pharma Latest Developments
13.3 Debiotech
13.3.1 Debiotech Company Information
13.3.2 Debiotech Microneedle Flu Vaccine Product Portfolios and Specifications
13.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Debiotech Main Business Overview
13.3.5 Debiotech Latest Developments
13.4 NanoPass Technologies
13.4.1 NanoPass Technologies Company Information
13.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
13.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 NanoPass Technologies Main Business Overview
13.4.5 NanoPass Technologies Latest Developments
13.5 Corium International
13.5.1 Corium International Company Information
13.5.2 Corium International Microneedle Flu Vaccine Product Portfolios and Specifications
13.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Corium International Main Business Overview
13.5.5 Corium International Latest Developments
13.6 Becton Dickinson and Company
13.6.1 Becton Dickinson and Company Company Information
13.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolios and Specifications
13.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Becton Dickinson and Company Main Business Overview
13.6.5 Becton Dickinson and Company Latest Developments
13.7 FluGen
13.7.1 FluGen Company Information
13.7.2 FluGen Microneedle Flu Vaccine Product Portfolios and Specifications
13.7.3 FluGen Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 FluGen Main Business Overview
13.7.5 FluGen Latest Developments
13.8 CosMED Pharmaceuticals
13.8.1 CosMED Pharmaceuticals Company Information
13.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolios and Specifications
13.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CosMED Pharmaceuticals Main Business Overview
13.8.5 CosMED Pharmaceuticals Latest Developments
13.9 Microdermics and OraSure Technologies
13.9.1 Microdermics and OraSure Technologies Company Information
13.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
13.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Microdermics and OraSure Technologies Main Business Overview
13.9.5 Microdermics and OraSure Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Microneedle Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Microneedle Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Solid Microneedle
Table 4. Major Players of Hollow Microneedle
Table 5. Major Players of Coated Microneedle
Table 6. Major Players of Dissolving Microneedle
Table 7. Global Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 8. Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Microneedle Flu Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Microneedle Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Microneedle Flu Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 12. Global Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 13. Global Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Microneedle Flu Vaccine Revenue by Application (2019-2024)
Table 15. Global Microneedle Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Microneedle Flu Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 17. Global Microneedle Flu Vaccine Sales by Company (2019-2024) & (K Dose)
Table 18. Global Microneedle Flu Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Microneedle Flu Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Microneedle Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Microneedle Flu Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 22. Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution and Sales Area
Table 23. Players Microneedle Flu Vaccine Products Offered
Table 24. Microneedle Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Microneedle Flu Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 28. Global Microneedle Flu Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Microneedle Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Microneedle Flu Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 32. Global Microneedle Flu Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Microneedle Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Microneedle Flu Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 36. Americas Microneedle Flu Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Microneedle Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Microneedle Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 40. Americas Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 41. APAC Microneedle Flu Vaccine Sales by Region (2019-2024) & (K Dose)
Table 42. APAC Microneedle Flu Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Microneedle Flu Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Microneedle Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. APAC Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Europe Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Europe Microneedle Flu Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Microneedle Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 52. Europe Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 53. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 54. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 58. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 59. Key Market Drivers & Growth Opportunities of Microneedle Flu Vaccine
Table 60. Key Market Challenges & Risks of Microneedle Flu Vaccine
Table 61. Key Industry Trends of Microneedle Flu Vaccine
Table 62. Microneedle Flu Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Microneedle Flu Vaccine Distributors List
Table 65. Microneedle Flu Vaccine Customer List
Table 66. Global Microneedle Flu Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 67. Global Microneedle Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 69. Americas Microneedle Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Microneedle Flu Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 71. APAC Microneedle Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 73. Europe Microneedle Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 75. Middle East & Africa Microneedle Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Microneedle Flu Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 77. Global Microneedle Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Microneedle Flu Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 79. Global Microneedle Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Sanofi Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Microneedle Flu Vaccine Product Portfolios and Specifications
Table 82. Sanofi Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Sanofi Main Business
Table 84. Sanofi Latest Developments
Table 85. GC Pharma Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. GC Pharma Microneedle Flu Vaccine Product Portfolios and Specifications
Table 87. GC Pharma Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. GC Pharma Main Business
Table 89. GC Pharma Latest Developments
Table 90. Debiotech Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Debiotech Microneedle Flu Vaccine Product Portfolios and Specifications
Table 92. Debiotech Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Debiotech Main Business
Table 94. Debiotech Latest Developments
Table 95. NanoPass Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. NanoPass Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
Table 97. NanoPass Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. NanoPass Technologies Main Business
Table 99. NanoPass Technologies Latest Developments
Table 100. Corium International Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Corium International Microneedle Flu Vaccine Product Portfolios and Specifications
Table 102. Corium International Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Corium International Main Business
Table 104. Corium International Latest Developments
Table 105. Becton Dickinson and Company Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolios and Specifications
Table 107. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Becton Dickinson and Company Main Business
Table 109. Becton Dickinson and Company Latest Developments
Table 110. FluGen Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. FluGen Microneedle Flu Vaccine Product Portfolios and Specifications
Table 112. FluGen Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. FluGen Main Business
Table 114. FluGen Latest Developments
Table 115. CosMED Pharmaceuticals Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolios and Specifications
Table 117. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. CosMED Pharmaceuticals Main Business
Table 119. CosMED Pharmaceuticals Latest Developments
Table 120. Microdermics and OraSure Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
Table 122. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Microdermics and OraSure Technologies Main Business
Table 124. Microdermics and OraSure Technologies Latest Developments
Table 1. Microneedle Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Microneedle Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Solid Microneedle
Table 4. Major Players of Hollow Microneedle
Table 5. Major Players of Coated Microneedle
Table 6. Major Players of Dissolving Microneedle
Table 7. Global Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 8. Global Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Microneedle Flu Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Microneedle Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Microneedle Flu Vaccine Sale Price by Type (2019-2024) & (US$/Dose)
Table 12. Global Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 13. Global Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Microneedle Flu Vaccine Revenue by Application (2019-2024)
Table 15. Global Microneedle Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Microneedle Flu Vaccine Sale Price by Application (2019-2024) & (US$/Dose)
Table 17. Global Microneedle Flu Vaccine Sales by Company (2019-2024) & (K Dose)
Table 18. Global Microneedle Flu Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Microneedle Flu Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Microneedle Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Microneedle Flu Vaccine Sale Price by Company (2019-2024) & (US$/Dose)
Table 22. Key Manufacturers Microneedle Flu Vaccine Producing Area Distribution and Sales Area
Table 23. Players Microneedle Flu Vaccine Products Offered
Table 24. Microneedle Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Microneedle Flu Vaccine Sales by Geographic Region (2019-2024) & (K Dose)
Table 28. Global Microneedle Flu Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Microneedle Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Microneedle Flu Vaccine Sales by Country/Region (2019-2024) & (K Dose)
Table 32. Global Microneedle Flu Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Microneedle Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Microneedle Flu Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 36. Americas Microneedle Flu Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Microneedle Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Microneedle Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 40. Americas Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 41. APAC Microneedle Flu Vaccine Sales by Region (2019-2024) & (K Dose)
Table 42. APAC Microneedle Flu Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Microneedle Flu Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Microneedle Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 46. APAC Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 47. Europe Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 48. Europe Microneedle Flu Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Microneedle Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 52. Europe Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 53. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2019-2024) & (K Dose)
Table 54. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2019-2024) & (K Dose)
Table 58. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2019-2024) & (K Dose)
Table 59. Key Market Drivers & Growth Opportunities of Microneedle Flu Vaccine
Table 60. Key Market Challenges & Risks of Microneedle Flu Vaccine
Table 61. Key Industry Trends of Microneedle Flu Vaccine
Table 62. Microneedle Flu Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Microneedle Flu Vaccine Distributors List
Table 65. Microneedle Flu Vaccine Customer List
Table 66. Global Microneedle Flu Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 67. Global Microneedle Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 69. Americas Microneedle Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Microneedle Flu Vaccine Sales Forecast by Region (2025-2030) & (K Dose)
Table 71. APAC Microneedle Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 73. Europe Microneedle Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Microneedle Flu Vaccine Sales Forecast by Country (2025-2030) & (K Dose)
Table 75. Middle East & Africa Microneedle Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Microneedle Flu Vaccine Sales Forecast by Type (2025-2030) & (K Dose)
Table 77. Global Microneedle Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Microneedle Flu Vaccine Sales Forecast by Application (2025-2030) & (K Dose)
Table 79. Global Microneedle Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Sanofi Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Microneedle Flu Vaccine Product Portfolios and Specifications
Table 82. Sanofi Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Sanofi Main Business
Table 84. Sanofi Latest Developments
Table 85. GC Pharma Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. GC Pharma Microneedle Flu Vaccine Product Portfolios and Specifications
Table 87. GC Pharma Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. GC Pharma Main Business
Table 89. GC Pharma Latest Developments
Table 90. Debiotech Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Debiotech Microneedle Flu Vaccine Product Portfolios and Specifications
Table 92. Debiotech Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Debiotech Main Business
Table 94. Debiotech Latest Developments
Table 95. NanoPass Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. NanoPass Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
Table 97. NanoPass Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. NanoPass Technologies Main Business
Table 99. NanoPass Technologies Latest Developments
Table 100. Corium International Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Corium International Microneedle Flu Vaccine Product Portfolios and Specifications
Table 102. Corium International Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Corium International Main Business
Table 104. Corium International Latest Developments
Table 105. Becton Dickinson and Company Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolios and Specifications
Table 107. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Becton Dickinson and Company Main Business
Table 109. Becton Dickinson and Company Latest Developments
Table 110. FluGen Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. FluGen Microneedle Flu Vaccine Product Portfolios and Specifications
Table 112. FluGen Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. FluGen Main Business
Table 114. FluGen Latest Developments
Table 115. CosMED Pharmaceuticals Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolios and Specifications
Table 117. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. CosMED Pharmaceuticals Main Business
Table 119. CosMED Pharmaceuticals Latest Developments
Table 120. Microdermics and OraSure Technologies Basic Information, Microneedle Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolios and Specifications
Table 122. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Microdermics and OraSure Technologies Main Business
Table 124. Microdermics and OraSure Technologies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Microneedle Flu Vaccine
Figure 2. Microneedle Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microneedle Flu Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Microneedle Flu Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Microneedle Flu Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Solid Microneedle
Figure 10. Product Picture of Hollow Microneedle
Figure 11. Product Picture of Coated Microneedle
Figure 12. Product Picture of Dissolving Microneedle
Figure 13. Global Microneedle Flu Vaccine Sales Market Share by Type in 2023
Figure 14. Global Microneedle Flu Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Microneedle Flu Vaccine Consumed in Influenza A
Figure 16. Global Microneedle Flu Vaccine Market: Influenza A (2019-2024) & (K Dose)
Figure 17. Microneedle Flu Vaccine Consumed in Influenza B
Figure 18. Global Microneedle Flu Vaccine Market: Influenza B (2019-2024) & (K Dose)
Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Application (2023)
Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Application in 2023
Figure 21. Microneedle Flu Vaccine Sales Market by Company in 2023 (K Dose)
Figure 22. Global Microneedle Flu Vaccine Sales Market Share by Company in 2023
Figure 23. Microneedle Flu Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Microneedle Flu Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Microneedle Flu Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 28. Americas Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 30. APAC Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 32. Europe Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Microneedle Flu Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Microneedle Flu Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Microneedle Flu Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Microneedle Flu Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Microneedle Flu Vaccine
Figure 74. Industry Chain Structure of Microneedle Flu Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Microneedle Flu Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Microneedle Flu Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Microneedle Flu Vaccine
Figure 2. Microneedle Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microneedle Flu Vaccine Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Microneedle Flu Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Microneedle Flu Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Solid Microneedle
Figure 10. Product Picture of Hollow Microneedle
Figure 11. Product Picture of Coated Microneedle
Figure 12. Product Picture of Dissolving Microneedle
Figure 13. Global Microneedle Flu Vaccine Sales Market Share by Type in 2023
Figure 14. Global Microneedle Flu Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Microneedle Flu Vaccine Consumed in Influenza A
Figure 16. Global Microneedle Flu Vaccine Market: Influenza A (2019-2024) & (K Dose)
Figure 17. Microneedle Flu Vaccine Consumed in Influenza B
Figure 18. Global Microneedle Flu Vaccine Market: Influenza B (2019-2024) & (K Dose)
Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Application (2023)
Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Application in 2023
Figure 21. Microneedle Flu Vaccine Sales Market by Company in 2023 (K Dose)
Figure 22. Global Microneedle Flu Vaccine Sales Market Share by Company in 2023
Figure 23. Microneedle Flu Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Microneedle Flu Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Microneedle Flu Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Microneedle Flu Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 28. Americas Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 30. APAC Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 32. Europe Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Microneedle Flu Vaccine Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa Microneedle Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Microneedle Flu Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Microneedle Flu Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Microneedle Flu Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Microneedle Flu Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Microneedle Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Microneedle Flu Vaccine
Figure 74. Industry Chain Structure of Microneedle Flu Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Microneedle Flu Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Microneedle Flu Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Microneedle Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Shoulder Elbow Wrist Hand Orthosis (SEWHO) Devices Market Growth 2023-2029
US$ 3,660.00
March 2023
109 pages
Global Fangcang Hospital Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
106 pages
Global Indoor Upholstery Fabrics Market Growth 2024-2030
US$ 3,660.00
November 2024
124 pages
Global Oncaspar Market Growth 2025-2031
US$ 3,660.00
January 2025
80 pages
Global Nasal Vaccines Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
